Aura Biosciences Inc (NASDAQ: AURA) announced the presentation of interim Phase 2 safety and efficacy data of belzupacap sarotalocan (bel-sar; AU-011) with 9-10 months of follow-up. The trial ...

Presenting data you have collected is one of the most challenging stages. Choosing the correct method of data presentation is important, and knowing how to complete a graph is an essential ...

Syndax (SNDX) Pharmaceuticals announced that 23 abstracts, including six oral presentations, showcasing compelling Revuforj and Niktimvo data were accepted for presentation at the 67th American ...

The Statistical & Data Sciences (SDS) Program links faculty and students from across the college interested in learning things from data. At Smith, students learn statistics by doing—class time ...